Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 100910
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100910
Table 1 Group characteristics according to the preoperative low anterior resection syndrome prediction model categories
ParametersAllNo LARS, %Minor LARS, %Major LARS, %P
No
vs minor
No
vs
major
Minor vs
major
Patients18626 (13.98)109 (58.6)51 (27.42)
Age in years 59.35 ± 10.2869.85 ± 8.0360.51 ± 8.8452.47 ± 9.14< 0.001< 0.001< 0.001
Sex0.0290.026< 0.001
    Male129 (69.35)23 (12.37)73 (39.25)33 (17.74)
    Female57 (30.65)3 (1.61)36 (19.35)18 (9.68)
TME/PME< 0.001< 0.001< 0.001
    TME82 (44.09)0 (0)34 (18.28)48 (25.81)    
    PME104 (55.91)26 (13.98)75 (40.32)3 (1.61)
Tumor height in cm9.08 ± 3.3213.69 ± 2.029.44 ± 2.606.08 ± 1.87< 0.001< 0.001< 0.001
Stoma86 (46.24)3 (1.61)37 (19.89)46 (24.73)0.024< 0.001< 0.001
Preoperative radiotherapy
51 (27.42)0 (0)17 (9.14)34 (18.28)0.043< 0.001< 0.001
Table 2 Relationship between EORTC QLQ-C30 score and preoperative low anterior resection syndrome score in postoperative patients with rectal cancer, n = 186
C30 scalesNo LARSMinor LARSMajor LARSP
No
vs minor
No
vs major
Minor
vs
major
Total26 (13.98)109 (58.60)51 (27.42)
PF87.69 ± 17.9688.38 ± 16.1688.37 ± 12.350.8360.6270.571
RF89.74 ± 17.6985.63 ± 21.3383.99 ± 19.990.3030.1630.47
EF88.78 ± 17.7988.46 ± 15.6387.25 ± 13.160.7730.2840.243
CF91.03 ± 15.0887.31 ± 15.3786.27 ± 15.880.1840.1540.713
SF83.33 ± 25.3981.80 ± 21.5873.53 ± 20.050.3860.0180.007
Fatigue21.37 ± 21.3024.87 ± 22.1728.32 ± 20.530.4730.1180.215
Nausea and vomiting1.92 ± 5.432.29 ± 7.342.29 ± 7.470.9630.8630.851
Pain8.33 ± 19.587.49 ± 13.8911.44 ± 17.790.5030.1570.166
Dyspnea3.85 ± 10.867.03 ± 14.408.50 ± 16.120.3040.2040.613
Sleep disturbance10.26 ± 15.6918.96 ± 25.4016.99 ± 23.450.1530.3090.688
Appetite loss8.97 ± 15.088.56 ± 15.325.23 ± 13.940.8410.1760.125
Constipation20.51 ± 26.7927.52 ± 26.0020.26 ± 25.010.1570.9380.069
Diarrhea12.82 ± 19.0416.51 ± 19.5824.18 ± 22.190.3540.0270.036
Financial impact11.54 ± 16.1717.74 ± 24.6728.10 ± 30.820.3820.0280.044
Global quality of life66.35 ± 27.5469.50 ± 23.4768.95 ± 18.710.7670.9650.67
Table 3 Relationship between the EORTC QLQ-CR29 score and preoperative low anterior resection syndrome score in postoperative patients with rectal cancer, n = 186
CR29 scalesNo LARSMinor LARSMajor LARSP
No
vs
minor
No
vs major
Minor
vs
major
Total26 (13.98)109 (58.60)51 (27.42)
Urinary frequency16.03 ± 19.1416.82 ± 18.3613.07 ± 13.870.7820.7640.36
Blood and mucus in stool3.21 ± 6.706.57 ± 11.1210.78 ± 13.260.1670.010.038
Body image14.53 ± 18.5315.09 ± 15.6819.83 ± 14.960.4630.0680.022
Flatulence25.76 ± 30.7428.18 ± 28.6034.67 ± 27.730.6230.1630.137
Fecal incontinence13.04 ± 26.0918.75 ± 23.6030.61 ± 28.740.1450.0060.013
Sore skin1.52 ± 7.116.25 ± 14.768.67 ± 17.570.1430.0670.416
Stool frequency23.91 ± 29.2323.20 ± 20.9134.69 ± 20.370.7030.0390.002
Embarrassment21.21 ± 37.8632.64 ± 31.7140.28 ± 33.660.0460.0120.215
Sexual interest (men)21.05 ± 25.3619.44 ± 23.5723.53 ± 25.330.7960.7070.384
Impotence11.76 ± 20.2123.23 ± 29.2228.13 ± 35.020.1370.1280.667
Sexual interest (women)111
Dyspareunia111
Urinary incontinence2.56 ± 9.065.50 ± 13.241.31 ± 6.530.2950.4840.033
Dysuria5.13 ± 15.472.14 ± 8.211.96 ± 7.920.350.3660.896
Abdominal pain7.69 ± 14.326.73 ± 14.899.15 ± 16.440.6190.7840.308
Buttock pain6.41 ± 18.906.73 ± 15.5711.76 ± 20.900.5480.1160.088
Bloating16.67 ± 21.6010.09 ± 16.6711.11 ± 18.460.1340.2440.842
Dry mouth12.82 ± 19.0419.57 ± 20.3920.26 ± 23.170.1110.180.976
Hair loss6.41 ± 13.4012.23 ± 22.5312.42 ± 18.810.3160.1770.577
Taste8.97 ± 17.783.67 ± 10.485.88 ± 14.460.0940.4210.385
Anxiety23.08 ± 26.2827.52 ± 25.1932.03 ± 26.630.3830.1570.304
Weight11.54 ± 18.7216.51 ± 22.9615.69 ± 21.450.3550.430.924
Table 4 Preoperative low anterior resection syndrome score and actual low anterior resection syndrome score crosstabulation
ParameterPOLARS score
Total


No LARS
Minor LARS
Major LARS
Actual LARS scoreNo LARS1025338
Minor LARS619631
Major LARS106542117
Total2610951186